Suppr超能文献

结核菌素与疫苗可预防的混淆:向美国疫苗与药品安全报告系统提交的报告

Preventable mix-ups of tuberculin and vaccines: reports to the US Vaccine and Drug Safety Reporting Systems.

作者信息

Chang Soju, Pool Vitali, O'Connell Kathryn, Polder Jacquelyn A, Iskander John, Sweeney Colleen, Ball Robert, Braun M Miles

机构信息

Office of Biostatistics and Epidemiology, US Food and Drug Administration (FDA), 1401 Rockville Pike, Rockville, MD 20852, USA.

出版信息

Drug Saf. 2008;31(11):1027-33. doi: 10.2165/00002018-200831110-00007.

Abstract

BACKGROUND

Errors involving the mix-up of tuberculin purified protein derivative (PPD) and vaccines leading to adverse reactions and unnecessary medical management have been reported previously.

OBJECTIVES

To determine the frequency of PPD-vaccine mix-ups reported to the US Vaccine Adverse Event Reporting System (VAERS) and the Adverse Event Reporting System (AERS), characterize adverse events and clusters involving mix-ups and describe reported contributory factors.

METHODS

We reviewed AERS reports from 1969 to 2005 and VAERS reports from 1990 to 2005. We defined a mix-up error event as an incident in which a single patient or a cluster of patients inadvertently received vaccine instead of a PPD product or received a PPD product instead of vaccine. We defined a cluster as inadvertent administration of PPD or vaccine products to more than one patient in the same facility within 1 month.

RESULTS

Of 115 mix-up events identified, 101 involved inadvertent administration of vaccines instead of PPD. Product confusion involved PPD and multiple vaccines. The annual number of reported mix-ups increased from an average of one event per year in the early 1990s to an average of ten events per year in the early part of this decade. More than 240 adults and children were affected and the majority reported local injection site reactions. Four individuals were hospitalized (all recovered) after receiving the wrong products. Several patients were inappropriately started on tuberculosis prophylaxis as a result of a vaccine local reaction being interpreted as a positive tuberculin skin test. Reported potential contributory factors involved both system factors (e.g. similar packaging) and human errors (e.g. failure to read label before product administration).

CONCLUSIONS

To prevent PPD-vaccine mix-ups, proper storage, handling and administration of vaccine and PPD products is necessary.

摘要

背景

先前已有报道称,结核菌素纯蛋白衍生物(PPD)与疫苗混淆导致不良反应及不必要的医疗处理的错误事件。

目的

确定向美国疫苗不良事件报告系统(VAERS)和不良事件报告系统(AERS)报告的PPD-疫苗混淆事件的频率,描述涉及混淆的不良事件和聚集情况,并阐述报告的促成因素。

方法

我们查阅了1969年至2005年的AERS报告以及1990年至2005年的VAERS报告。我们将混淆错误事件定义为单个患者或一组患者无意中接种了疫苗而非PPD产品,或接种了PPD产品而非疫苗的事件。我们将聚集定义为在1个月内在同一机构内对多名患者无意中接种了PPD或疫苗产品。

结果

在确定的115起混淆事件中,101起涉及无意中接种了疫苗而非PPD。产品混淆涉及PPD和多种疫苗。报告的混淆事件年数量从20世纪90年代初的平均每年1起增加到本十年初的平均每年10起。超过240名成人和儿童受到影响,大多数报告了局部注射部位反应。4人在接种错误产品后住院(均康复)。由于疫苗局部反应被解释为结核菌素皮肤试验阳性,几名患者被不恰当地开始进行结核病预防。报告的潜在促成因素涉及系统因素(如包装相似)和人为错误(如在产品给药前未阅读标签)。

结论

为防止PPD-疫苗混淆,疫苗和PPD产品的妥善储存、处理和给药是必要的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验